1Wardlaw A J, Hay H, Cromwell O, et al. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol, 1989, 84 (1): 19-26.
2Drazen JM, O'Brien J, Sparrow D, et al. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis, 1992, 146(1) : 104-108.
3TheSubspecialtyGroupofRespiratoryDiseases theSocietyofPediatrics ChineseMedicalAssociation(中华医学会儿科学分会呼吸学组) theEditorialBoard ChineseJournalofPediatrtics(《中华儿科杂志》编委会).Guideline for the diagnosis and optimal management of asthma in children[J].中华儿科杂志,2008,:745-753.
4Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy, 2008, 63 ( 1 ) : 5-34.
5Global strategy for the diagnosis and management of asthma in children 5 years and younger, Global Initiative for Asthma (GINA) 2009. 2011-3-11. http://www, ginasthma, org / Guidelineitem. asp?? 11 =2&12 = l&intld = 1689.
6Pedersen SE, Hurd SS, Lemanske RF Jr, et al. Global strategy for the diagnosis and management of asthma in children 5 yearsand younger. Pediatr Pulmonol, 2011,46( 1 ) : 1-17.
7Montuschi P, Mondino C, Koch P, et al. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest, 2007, 132 (6) : 1876-1881.
8Yuksel B, Aydemir C, Ustundag G, et al. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma. Turk J Pediatr, 2009, 51 (5): 460-465.
9Philip G, Pedinoff A, Vandormael K, et al. A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma. J Asthma, 2010, 47(10) : 1078-1084.
10Zhu ML (朱明亮 ), He S. Efficacy of montelukas in the prevention of acute asthma episode in children. Chin J Contemp Pediatr( 中国当代儿科杂志), 2009, 11(8): 695-696.
